Cellvax is a service company which provides complete preclinical innovating services allowing to accelerate the drug development process for unmet needs related to severe human diseases, cancer, diabetes, etc...
News
Drug Validation Models
Other Preclinical Services
07/09/2007 Cellvax awarded by European Program Eureka, Oligoclonics
Cellvax was awarded by European Program, Eureka, named "Oligoclonics" with another french partner and three partners in the Netherland. For more information, please visit Eureka web site: www.eureka.be
01/01/2005 BIO-Europe (November, 2008)
Cellvax will be participating the meeting BIO-Europe on November 17th - 19th 2008 in Heidelberg, Germany. We will be happy to meet you there in order to discuss our possible collaborations.